CPRX Q4 2017 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

CPRXCatalyst Pharmaceuticals, Inc.

$3B

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$3M

Operating Income

-$6M

Net Income

-$5M

EPS (Diluted)

$-0.06

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$485,510

Balance Sheet

Total Assets

$85M

Total Liabilities

$4M

Stockholders' Equity

$81M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$3M	-$3M	-20.7%
Operating Income	-$6M	-$4M	-27.8%
Net Income	-$5M	-$4M	-29.4%